Griffon Corporation's Joint Venture with ONCAP: A Strategic Analysis
Griffon Corporation's recent joint venture with ONCAP marks a significant consolidation in the tools and outdoor equipment sector.
Lisata Therapeutics: Analyzing the $4.00 Per Share Tender Offer from Kuva Labs
Lisata Therapeutics stockholders face a pivotal moment with a $4.00 per share cash tender offer from Kuva Labs.
Trade with the conviction of the 1%.
Institutional-grade market intelligence delivered before the opening bell.
Figure Technology's Acquisition of Kiavi: A Strategic Move in Blockchain Lending
Figure Technology's acquisition of Kiavi aims to enhance its blockchain capabilities in real estate lending.
APA Corporation's Strategic Acquisition: Strengthening Alaska's Energy Sector
APA Corporation's latest acquisition bolsters its role in Alaska's energy landscape, reflecting broader US energy indepe…
Trump Media & Technology Group and TAE Technologies: Merger Update Insights
Merger update from Trump Media & Technology Group with TAE Technologies holds key insights for investors amid volatility…
Ingredion's $4.2 Billion Acquisition of Tate & Lyle: A Game Changer in Food Ingredients
Ingredion's acquisition of Tate & Lyle for $4.2 billion could reshape the food ingredients landscape.
Standard BioTools and Treeline Biosciences Merge: A New Force in Drug Discovery
The merger between Standard BioTools and Treeline Biosciences is set to reshape drug discovery with enhanced capabilitie…
Factorial's Nasdaq Listing: A New Era for Solid-State Battery Technology
Factorial's debut on Nasdaq signals a pivotal moment for solid-state battery technology and its commercialization.
SUNation Energy's Stock Soars: What the Suniva Merger Means for Investors
SUNation Energy's shares have more than doubled after a reverse merger with Suniva, signaling a transformative moment in…
Incyte's $1.25 Billion Acquisition of Vega: A Strategic Expansion in Immunology
Incyte's acquisition of Vega Therapeutics for $1.25 billion signals a significant expansion in its immunology portfolio.
Standard BioTools and Treeline Biosciences: A New Era in Biotech Mergers
The merger between Standard BioTools and Treeline Biosciences signals a pivotal shift in the biotech landscape, focusing…